TMA technology ›
With fewer steps and less processing time than other NAT methods, TMA technology reduces the risk of contamination and streamlines workflow for faster results.
Instruments ›
Novartis Diagnostics offers the only two fully integrated and automated platforms for NAT blood screening.
Software ›
PROCLEIX® NAT TRACKER® and Pooling Software manage results produced with PROCLEIX® Assays using PROCLEIX® Instruments.
Assays ›
Novartis Diagnostics' PROCLEIX® Assays are used for blood screening to detect viral RNA and DNA during the very early stages of infection.
About Novartis Vaccines
Novartis Vaccines is a leader in providing products to fight more than 20 vaccine-preventable viral and bacterial diseases. Novartis Vaccines is the division researching novel treatments.